Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phathom Pharmaceuticals (PHAT) Other Non-Current Assets: 2022-2025

Historic Other Non-Current Assets for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $2.9 million.

  • Phathom Pharmaceuticals' Other Non-Current Assets changed negligibly% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.9 million for FY2024, which is 0.03% down from last year.
  • Latest data reveals that Phathom Pharmaceuticals reported Other Non-Current Assets of $2.9 million as of Q3 2025, which was down 0.00% from $2.9 million recorded in Q2 2025.
  • In the past 5 years, Phathom Pharmaceuticals' Other Non-Current Assets ranged from a high of $3.8 million in Q3 2023 and a low of $505,000 during Q4 2022.
  • Moreover, its 3-year median value for Other Non-Current Assets was $2.9 million (2025), whereas its average is $2.8 million.
  • In the last 5 years, Phathom Pharmaceuticals' Other Non-Current Assets slumped by 37.27% in 2023 and then surged by 467.72% in 2024.
  • Phathom Pharmaceuticals' Other Non-Current Assets (Quarterly) stood at $505,000 in 2022, then surged by 466.93% to $2.9 million in 2023, then declined by 0.03% to $2.9 million in 2024, then remained steady at $2.9 million in 2025.
  • Its Other Non-Current Assets stands at $2.9 million for Q3 2025, versus $2.9 million for Q2 2025 and $2.9 million for Q1 2025.